G-CSF (Filgrastim)
Sponsors
M.D. Anderson Cancer Center, Maria Sklodowska-Curie National Research Institute of Oncology, Fakultas Kedokteran Universitas Indonesia, Yaqrit Ltd, Blokhin's Russian Cancer Research Center
Conditions
Acute-On-Chronic Liver FailureAlcoholic HepatitisGerm Cell Cancer MetastaticHodgkin's LymphomaLeukemiaLiver CirrhosisLiver Cirrhosis, AlcoholicLymphoma
Phase 2
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
CompletedNCT00857389
Start: 2009-03-02End: 2019-03-09Updated: 2020-04-07
A-TANGO Phase 2 Study
RecruitingNCT06890039
Start: 2026-06-29End: 2028-12-31Target: 78Updated: 2026-09-21
Paclitaxel-Bleomycin/Etoposide/Cisplatin vs Bleomycin/Etoposide/Cisplatin in Poor-prognosis Non-seminomatous Germ Cell Tumors (NSGCT) and Unfavorable Tumor Marker Decline
RecruitingNCT07847190
Start: 2024-10-01End: 2029-10-01Target: 60Updated: 2026-10-26
Phase 3
Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Multiple Myeloma Patients.
CompletedNCT01908621
Start: 2013-03-20End: 2017-10-27Updated: 2018-08-28
Randomized Trial of G-CSF Alone Versus Intermediate-dose Ara-C Plus G-CSF Mobilization in Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
NCT02722733
Start: 2016-03-31End: 2017-04-30Target: 90Updated: 2016-03-30
Granulocyte-Colony Stimulating Factor (G-CSF) as Optimizing Therapy for Pediatric Liver Transplantation
CompletedNCT04113317
Start: 2020-01-01End: 2022-02-28Updated: 2022-07-27